Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Clinical Trial Facility
mi
from
Austin, TX
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Austin, TX
Wait-list Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder (OCD)
Wait-list Feasibility Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric OCD
Status: Archived
Univeristy of South Florida
mi
from
Tampa, FL
Wait-list Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder (OCD)
Wait-list Feasibility Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric OCD
Status: Archived
Updated: 1/1/1970
Univeristy of South Florida
mi
from
Tampa, FL
Wait-list Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder (OCD)
Wait-list Feasibility Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric OCD
Status: Archived
Mayo Clinic Rochester
mi
from
Rochester, MN
Wait-list Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder (OCD)
Wait-list Feasibility Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric OCD
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
Wait-list Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder (OCD)
Wait-list Feasibility Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric OCD
Status: Archived
Fordham University
mi
from
Bronx, NY
Wait-list Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder (OCD)
Wait-list Feasibility Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric OCD
Status: Archived
Updated: 1/1/1970
Fordham University
mi
from
Bronx, NY
Family Therapy as Hospital Aftercare for Adolescent Suicide Attempters
Family Therapy as Hospital Aftercare for Adolescent Suicide Attempters
Status: Archived
Children's Hospital at Downstate
mi
from
Brooklyn, NY
Family Therapy as Hospital Aftercare for Adolescent Suicide Attempters
Family Therapy as Hospital Aftercare for Adolescent Suicide Attempters
Status: Archived
Updated: 1/1/1970
Children's Hospital at Downstate
mi
from
Brooklyn, NY
Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4451
A Phase I, Randomized, Double- Blind, Placebo- Controlled, Single-center Study, to Assess the Safety, Tolerability and Pharmacokinetics of AZD4451 Following Single Ascending Oral Dose Administration in Healthy Subjects
Status: Archived
Clinical Research Facility
mi
from
Kansas City, KA
Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4451
A Phase I, Randomized, Double- Blind, Placebo- Controlled, Single-center Study, to Assess the Safety, Tolerability and Pharmacokinetics of AZD4451 Following Single Ascending Oral Dose Administration in Healthy Subjects
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Kansas City, KA
Pilot Study of a Text Message Platform to Reduce Risky Drinking in Young Adults
Pilot Study of a Computer-driven Platform That Uses Text Messages to Collect Drinking Information and Deliver Personalized Motivational Messages to At-risk Young Adults
Status: Archived
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Pilot Study of a Text Message Platform to Reduce Risky Drinking in Young Adults
Pilot Study of a Computer-driven Platform That Uses Text Messages to Collect Drinking Information and Deliver Personalized Motivational Messages to At-risk Young Adults
Status: Archived
Updated: 1/1/1970
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Medications Development for the Treatment of Cannabis Related Disorders
Medications Development for the Treatment of Cannabis Related Disorders
Status: Archived
University of Virginia Health Systems
mi
from
Charlottesville, VA
Medications Development for the Treatment of Cannabis Related Disorders
Medications Development for the Treatment of Cannabis Related Disorders
Status: Archived
Updated: 1/1/1970
University of Virginia Health Systems
mi
from
Charlottesville, VA
Medications Development for the Treatment of Cannabis Related Disorders
Medications Development for the Treatment of Cannabis Related Disorders
Status: Archived
University of Virginia
mi
from
Charlottesville, VA
Medications Development for the Treatment of Cannabis Related Disorders
Medications Development for the Treatment of Cannabis Related Disorders
Status: Archived
Updated: 1/1/1970
University of Virginia
mi
from
Charlottesville, VA
A Study to Evaluate the Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (Study P06522)
A Sequential Groups, Open Label, Rising Multiple Dose Study to Assess the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder
Status: Archived
Clinical Research Facility
mi
from
Atlanta, GA
A Study to Evaluate the Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (Study P06522)
A Sequential Groups, Open Label, Rising Multiple Dose Study to Assess the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Atlanta, GA
A Study to Evaluate the Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (Study P06522)
A Sequential Groups, Open Label, Rising Multiple Dose Study to Assess the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder
Status: Archived
Clinical Research Facility
mi
from
Houston, TX
A Study to Evaluate the Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (Study P06522)
A Sequential Groups, Open Label, Rising Multiple Dose Study to Assess the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Houston, TX
Ketamine for Low Mood States in the ER
Low Dose Ketamine for Low Mood States: An Emergency Department Feasibility Study for Depressed Patients
Status: Archived
Yale University School of Medicine
mi
from
New Haven, CT
Ketamine for Low Mood States in the ER
Low Dose Ketamine for Low Mood States: An Emergency Department Feasibility Study for Depressed Patients
Status: Archived
Updated: 1/1/1970
Yale University School of Medicine
mi
from
New Haven, CT
Oxytocin Treatment of Alcohol Withdrawal
Oxytocin Treatment of Alcohol Withdrawal
Status: Archived
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Oxytocin Treatment of Alcohol Withdrawal
Oxytocin Treatment of Alcohol Withdrawal
Status: Archived
Updated: 1/1/1970
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Oxytocin Treatment of Alcohol Withdrawal
Oxytocin Treatment of Alcohol Withdrawal
Status: Archived
Central Regional Hospital
mi
from
Raleigh, NC
Oxytocin Treatment of Alcohol Withdrawal
Oxytocin Treatment of Alcohol Withdrawal
Status: Archived
Updated: 1/1/1970
Central Regional Hospital
mi
from
Raleigh, NC
Studying Amphetamine Withdrawal in Humans
Amphetamine Withdrawal Paradigm in Humans
Status: Archived
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Studying Amphetamine Withdrawal in Humans
Amphetamine Withdrawal Paradigm in Humans
Status: Archived
Updated: 1/1/1970
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Follow Up of Gestational Carriers and Intended Parents
Follow Up of Gestational Carriers and Intended Parents
Status: Archived
Reproductive Medicine Associates of New Jersey
mi
from
Morristown, NJ
Follow Up of Gestational Carriers and Intended Parents
Follow Up of Gestational Carriers and Intended Parents
Status: Archived
Updated: 1/1/1970
Reproductive Medicine Associates of New Jersey
mi
from
Morristown, NJ
Efficacy of a Brief Nightmare Treatment for Veterans
Efficacy of a Brief Nightmare Treatment for Veterans
Status: Archived
The University of Tulsa
mi
from
Tulsa, OK
Efficacy of a Brief Nightmare Treatment for Veterans
Efficacy of a Brief Nightmare Treatment for Veterans
Status: Archived
Updated: 1/1/1970
The University of Tulsa
mi
from
Tulsa, OK
Young Women's CoOp Study
Adapting the Women's CoOp for At-Risk Teens
Status: Archived
RTI International; Substance Abuse Treatment Evaluations and Interventions (SATEI) Community-Based Field Site - Durham
mi
from
Durham, NC
Young Women's CoOp Study
Adapting the Women's CoOp for At-Risk Teens
Status: Archived
Updated: 1/1/1970
RTI International; Substance Abuse Treatment Evaluations and Interventions (SATEI) Community-Based Field Site - Durham
mi
from
Durham, NC
Young Women's CoOp Study
Adapting the Women's CoOp for At-Risk Teens
Status: Archived
RTI International - Wake County Field Site
mi
from
Raleigh, NC
Young Women's CoOp Study
Adapting the Women's CoOp for At-Risk Teens
Status: Archived
Updated: 1/1/1970
RTI International - Wake County Field Site
mi
from
Raleigh, NC
Young Women's CoOp Study
Adapting the Women's CoOp for At-Risk Teens
Status: Archived
RTI International - Headquarters
mi
from
Research Triangle Park, NC
Young Women's CoOp Study
Adapting the Women's CoOp for At-Risk Teens
Status: Archived
Updated: 1/1/1970
RTI International - Headquarters
mi
from
Research Triangle Park, NC
Guitars for Vets: Evaluating Psychological Outcome of a Novel Music Therapy
Guitars for Vets: Evaluating Psychological Outcome of a Novel Music Therapy
Status: Archived
Zablocki VA Medical Center, Milwaukee
mi
from
Milwaukee, WI
Guitars for Vets: Evaluating Psychological Outcome of a Novel Music Therapy
Guitars for Vets: Evaluating Psychological Outcome of a Novel Music Therapy
Status: Archived
Updated: 1/1/1970
Zablocki VA Medical Center, Milwaukee
mi
from
Milwaukee, WI
A Study of Brain Receptor Occupancy in Healthy Subjects
Assessment of Brain Kappa Opioid Receptor Occupancy After Single Oral Doses of LY2456302 as Measured by PET With Radioligand LY2879788 in Healthy Subjects
Status: Archived
Clinical Research Facility
mi
from
Hartford, CT
A Study of Brain Receptor Occupancy in Healthy Subjects
Assessment of Brain Kappa Opioid Receptor Occupancy After Single Oral Doses of LY2456302 as Measured by PET With Radioligand LY2879788 in Healthy Subjects
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Hartford, CT
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site #215
mi
from
Birmingham, AL
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site #215
mi
from
Birmingham, AL
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site 095
mi
from
Hoover, AL
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site 095
mi
from
Hoover, AL
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site #014
mi
from
Huntsville, AL
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site #014
mi
from
Huntsville, AL
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site #146
mi
from
Mobile, AL
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site #146
mi
from
Mobile, AL
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site #171
mi
from
Chandler, AZ
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site #171
mi
from
Chandler, AZ
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site 145
mi
from
Glendale, AZ
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site 145
mi
from
Glendale, AZ
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site 027
mi
from
Glendale, AZ
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site 027
mi
from
Glendale, AZ
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site 121
mi
from
Phoenix, AZ
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site 121
mi
from
Phoenix, AZ
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site 137
mi
from
Tucson, AZ
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site 137
mi
from
Tucson, AZ
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site 052
mi
from
Hot Springs, AR
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site 052
mi
from
Hot Springs, AR
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site 155
mi
from
Little Rock, AR
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site 155
mi
from
Little Rock, AR
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site #182
mi
from
Buena Park, CA
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site #182
mi
from
Buena Park, CA
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site 162
mi
from
Sacramento, CA
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site 162
mi
from
Sacramento, CA
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site 008
mi
from
San Diego, CA
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site 008
mi
from
San Diego, CA
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site 159
mi
from
Walnut Creek, CA
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site 159
mi
from
Walnut Creek, CA
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site 007
mi
from
Denver, CO
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site 007
mi
from
Denver, CO
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site #216
mi
from
Denver, CO
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site #216
mi
from
Denver, CO
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site 026
mi
from
Lakewood, CO
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site 026
mi
from
Lakewood, CO
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
The Hospital of Central Connecticut at New Britain General
mi
from
New Britain, CT
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
The Hospital of Central Connecticut at New Britain General
mi
from
New Britain, CT
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Coastal Connecticut Research, LLC
mi
from
New London, CT
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
Coastal Connecticut Research, LLC
mi
from
New London, CT
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site 036
mi
from
Ridgefield, CT
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site 036
mi
from
Ridgefield, CT
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site 143
mi
from
Jacksonville, FL
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site 143
mi
from
Jacksonville, FL
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site 024
mi
from
Miami, FL
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site 024
mi
from
Miami, FL
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site #111
mi
from
Orlando, FL
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site #111
mi
from
Orlando, FL
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site #219
mi
from
Pinellas Park, FL
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site #219
mi
from
Pinellas Park, FL
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site 041
mi
from
St. Petersburg, FL
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site 041
mi
from
St. Petersburg, FL
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site 115
mi
from
Atlanta, GA
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site 115
mi
from
Atlanta, GA
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
BioSante Site #141
mi
from
Roswell, GA
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder
A Phase III, Multi-Center Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Status: Archived
Updated: 1/1/1970
BioSante Site #141
mi
from
Roswell, GA